Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Region Skane
180 participants
Oct 23, 2024
INTERVENTIONAL
Conditions
Summary
Adenosine is a commonly used pharmaceutical stressor at cardiac magnetic resonance examinations to assess suspected chronic coronary syndrome (CCS). However, several studies have reported that the current use of adenosine does not induce adequate hyperemic response in a substantial number of patients, leading to false diagnostics. The aim of this trial is to investigate the hyperemic effect of the standard dose of adenosine (140 microgram/kg/min) to the high dose of adenosine (210 microgram/kg/min) to improve the diagnostic methods using adenosine as a stressor and ultimately improve treatment decisions and patient prognosis in CCS.
Eligibility
Inclusion Criteria7
- Patients:
- The subject has given their written consent to participate in the trial.
- Are referred to Department of Clinical Physiology, Skåne University Hospital, for suspected or known CCS or heart failure
- No caffein intake <24h prior to the examination
- Healthy volunteers:
- The subject has given their written consent to participate in the trial.
- No caffein intake <24h prior to the examination
Exclusion Criteria26
- Patients:
- Acute referral (in-house patients)
- Clinically unstable
- Acute chest pain
- Severe or decompensated heart failure
- Non sinus rhythm (e.g. atrial fibrillation)
- Asthma or severe chronic obstructive pulmonary disease
- Known chronic renal failure (eGFR <45mL/min/1.73m2)
- AV-block II or III
- Left Bundle Branch Block
- Systolic blood pressure <90 mmHg or >230 mmHg at rest
- Increased intracranial pressure
- Known allergy or adverse reaction to adenosine or mannitol
- Known allergy or adverse reaction to gadolinium contrast agents
- Treatment with medication containing dipyradimol or teofyllamin/teofyllin
- Claustrophobia
- Devices contraindicated to CMR imaging (pacemaker, implants, intracranial clips etc)
- Pregnancy or breast feeding (screened by question only)
- Inability to give informed consent due to mental state, language difficulties etc
- Healthy volunteers:
- Blood pressure > 140/90 measured according to clinical routine
- Known systemic disease
- Known cardiac disease
- Cardiovascular medication
- Medication that might influence cardiovascular health
- Smoking
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard dose 140 μg/kg/min and high dose 210 μg/kg/min adenosine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06578234